Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome

Author： Christakou Charikleia D   Diamanti-Kandarakis Evanthia  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.4, Iss.6, 2008-11, pp. : 583-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 12, 2015-12 ,pp. : 1247-1254

John Wiley & Sons Inc

Access to resources Recommend Favorite

The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta‐analysis

By  

CLINICAL ENDOCRINOLOGY, Vol. 88, Iss. 2, 2018-02 ,pp. : 169-184

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 1-6349, Iss. 10, 2015-10 ,pp. : 1082-1089

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 10, 2015-10 ,pp. : 1082-1089

John Wiley & Sons Inc

Access to resources Recommend Favorite

Haemoglobin, C-reactive protein and androgen levels in uncomplicated and complicated pregnancies of women with polycystic ovary syndrome

By Vanky Eszter   Salvesen Kjell Å.   Åsberg Arne   Carlsen Sven  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 5, 2008-01 ,pp. : 421-426

Informa Healthcare

Access to resources Recommend Favorite